Background. Body surface maps of net QRST deflection areas (isointegrals) reflect regional ventricular repolarization properties. Vulnerability to ventricular tachyarrhythmias is associated with maps that feature multiple islands (extrema) of positive and negative values; such maps reflect regional disparity of ventricular recovery properties. The value of body surface mapping in prediction of the efficacy of antiarrhythmic therapy for ventricular tachyarrhythmias has not been determined.
proach requires invasive instrumentation and the purposeful induction of life-threatening ventricular tachyarrhythmias. Accordingly, many investigators have been interested in developing noninvasive methods to assess vulnerability to ventricular tachyarrhythmias. In this regard, signal-averaged ECG detection of late potentials representing areas of slow intraventricular conduction has received considerable attention.4-Another correlate of vulnerability to ventricular tachyarrhythmias is regional disparity of ventricular recovery properties7'8 providing a substrate for the unidirectional block required for reentrant tachyarrhythmias.
In the absence of regional differences in ventricular action potential characteristics, the area under the QRST deflection of the body surface ECG would be zero.9 Thus, the observed nonzero nature of the area under the QRST deflection reflects regional differences in ventricular action potential characteristics. Although regional differences in any action potential characteristic may contribute to the nonzero nature of QRST integrals, including differences in regional ventricular activation times,10 Abildskov and coworkers11"2 have demonstrated that changes in QRST integrals are primarily the result of changes in regional ventricular recovery times. We13,14 and others15'16 have used this approach and have reported that ECG body surface mapping of QRST integrals can identify patients with vulnerability to ventricular tachyarrhythmias. To date, however, the ability of ECG body surface mapping to predict the efficacy of prophylactic, antiarrhythmic drug therapy has not been assessed.
In the present study, we have used the body surface mapping technique to acquire QRST-integral maps from patients presenting with documented, symptomatic ventricular tachyarrhythmias in whom ventricular tachycardia could be reproducibly induced by programmed ventricular stimulation. Maps were acquired in the baseline, antiarrhythmic drug-free state and after oral quinidine therapy. The purpose of this analysis was to determine whether there were features in the baseline maps that might predict which patients would benefit from quinidine therapy and whether changes in the maps resulting from therapy would correlate with antiarrhythmic drug efficacy.
Methods

Patient Population
The study group consisted of 51 consecutive patients presenting with ECG-documented, symptomatic ventricular tachyarrhythmias occurring in the absence of a transient or reversible cause. All patients had ventricular tachycardia reproducibly induced by programmed ventricular stimulation and underwent a trial of oral quinidine therapy that was assessed by repeated programmed ventricular stimulation. Fifty-one age-and sex-matched normal subjects served as control subjects for the QRST-integral map analysis. This study and its consent form were approved by the Conjoint Medical Ethics Committee of the Foothills Hospital and University of Calgary.
Programmed Ventricular Stimulation
Programmed ventricular stimulation studies were performed at baseline, while the patient was receiving no antiarrhythmic drug therapy, and were repeated at steady state after at least 2 days of oral quinidine therapy at the maximum well-tolerated dosage. Transvenous electrode catheters were inserted while the patient was under local anesthesia with diluted (0.33%) lidocaine. The rationale of our ventricular stimulation protocol has been described previously.17 Stimuli 2 msec in duration with an intensity of twice the diastolic threshold were applied to the right ventricular apex. Single, double, and triple extrastimuli scanned diastole after eight-beat trains of ventricular pacing at cycle lengths of 600, 500, and 400 msec. Thereafter, sixand 12-beat trains of rapid ventricular pacing at cycle lengths of 300 to 240 msec (in 10-msec decrements) were applied. If ventricular tachycardia was not reproducibly induced, the stimulation protocol was repeated from the right ventricular outflow tract. The end point of stimulation was completion of the protocol or induc-FIGURE 1. Normal QRST-integral body surface map averaged from 51 control group patients. Rectangular area represents torso with both left and right margins corresponding to right midaxillary line. Left half of rectangle corresponds to anterior torso, and right half corresponds to the back. Maximum positive and negative extrema are indicated (microvoltseconds).
tion of sustained ventricular tachycardia. Reproducibility was demonstrated by the induction of ventricular tachycardia at least twice. Catheters were reinserted for the subsequent drug assessment study,18 and the ventricular stimulation protocol was repeated from that single site permitting reproducible ventricular tachycardia induction at baseline.
ECG Body Surface Mapping
Each patient underwent ECG body surface mapping in an antiarrhythmic drug-free state and after receiving oral quinidine therapy for at least 2 days at the maximum well-tolerated dosage. ECG body surface maps were recorded within 24 hours of their corresponding programmed ventricular stimulation study.
Maps were recorded with patients in the supine position. Digitized ECG signals were recorded simultaneously from 117 torso leads and three limb leads, with Wilson's central terminal as a reference. These leads were sampled at 500 samples per second per channel and were processed off-line with a Stellar GS 1000 computer (Stardent Computer Inc., Concord, Mass.). Ectopic beats and artifacts were eliminated, and average complexes were constructed for each lead from 15 seconds of continuous recording with the TP segment as the baseline. Averaged Frank X, Y, and Z leads were superimposed for determination of QRS duration and for identification of the time instants of onset of the QRS complex and offset of the T wave. The QRST time integrals (microvolt-seconds) were calculated for each lead. QRST-integral maps were obtained by interpolations of the 117 known values to an array of 65x37 data points, with column 65 being identical to column 1.
The display format, previously described,'9 is illustrated in Figure 1 . The rectangular area represents the torso, with both left and right margins corresponding to the right midaxillary line. Thus, the left half of each rectangle represents the anterior torso, and the right half represents the posterior torso. The upper border corresponds to the neck and the lower border to the waist. Points of equal integral value are connected by contour linespositive values by solid contour lines, negative values by interrupted contour lines. The contours progress logarithmically (e.g., ... 10, 15, 22, 33, 47, 68, 100, 150.. .). Only seven contours are plotted, starting from that nearest to the largest extremum and progressing through the scale toward zero. Mirror con- tours of opposite polarity are also plotted. The principal extrema are identified, with the numerical value of the amplitude in microvolt-seconds. Previous studies have documented that normal adults have a smooth dipolar distribution of QRST time integrals with one positive and one negative peak, 19 whereas patients vulnerable to ventricular tachyarrhythmias tend to have numerous negative and positive extrema constituting a distinctively nondipolar integral map. 13 Accordingly, the multipolar content of each map was determined by counting separate positive and negative extrema. Viewing the display as a topographical map, separate peaks or nadirs of QRST integrals were counted as defined by the contour program discussed above. As reported previously,13 when the projection format split negativity over the right shoulder into anterior and posterior troughs, this negativity was treated as one extremum. For the purposes of this study, maps with three or more extrema were considered to be multipolar. Extrema counting was performed by one experienced individual (E.R.S.) blinded to other study data.
The Karhunen-Loeve transform20 was applied to the QRST-integral maps, each of which comprised 117 integral values. Specifically, a sample covariance matrix was calculated for each set of data. The eigenvalues and eigenvectors of each covariance matrix were computed by NAG library routines (Numerical Algorithms Group, Inc., Downers Grove, Ill.) for a real symmetric matrix. Twelve spatial eigenvector patterns were displayed as body surface maps for each set of data. The information content of each eigenvector pattern was measured as a percentage of the trace of each sample covariance matrix.15,20 The first three patterns in all sets were dipolar in character, whereas patterns 4 through 12 were multipolar. Each individual map was represented as a linear combination of eigenvector distributions. A set of weighting coefficients derived in this fashion was used to calculate the dipolar content of each map. This dipolar content was expressed as the percentage contri-bution of eigenvectors beyond the third to the total signal energy of the map.2'
Statistical Analysis
Data are presented as mean±SD and were compared with paired Student's t tests, unpaired Student's t tests, and one-way ANOVA (with Duncan's multiple-range test) as appropriate. Proportional differences were assessed by x2 analysis. Associations between QRSTintegral map data and the characteristics of induced ventricular tachycardia were sought with linear regression techniques. The performance characteristics of QRST-integral map data using various decision thresholds in discriminating between ventricular tachycardia patients and normal subjects and between ventricular tachycardia patients for whom quinidine was and those for whom quinidine was not effective therapy were evaluated by receiver operating characteristic analysis.22
The null hypothesis was rejected when the two-tailed probability value was less than 0.05.
Results
Patient Population
The demographic characteristics of the 51 patients composing the primary study population are shown in Table 1 . The group consisted predominantly of middleaged men with coronary artery disease and remote myocardial infarction. Most patients had poor left ventricular function. Quinidine therapy prevented ventricular tachyarrhythmia induction by programmed ventricular stimulation and was therefore considered to be effective therapy in 14 patients. The remaining 37 patients continued to have inducible ventricular tachycardia despite quinidine therapy. Comparisons of the demographic characteristics of these two subgroups of patients are also shown in Table 1 .
Compared with patients for whom quinidine was effective therapy, patients for whom quinidine was not effective therapy were significantly more likely to have structural heart disease and significantly more likely to have atherosclerotic heart disease. Accordingly, in the BASELINE QUINIDINE BASELINE QUINIDINE analyses that follow, data are presented both for the total group of patients and for the subgroup with atherosclerotic heart disease.
QRS Durations
As shown in Table 1 , there were no significant differences among the mean baseline QRS durations of the total ventricular tachycardia population, those patients for whom quinidine was effective therapy, and those patients for whom quinidine was not effective therapy. Although quinidine therapy increased QRS durations in each group, the changes were equivalent among these three groups such that there were no significant differences among the mean treatment QRS durations. A similar pattern of change was observed in the subgroup of patients with atherosclerotic heart disease. At baseline, the mean QRS duration of patients with atherosclerotic heart disease for whom quinidine was effective therapy (112+20 msec) was identical to that of patients with atherosclerotic heart disease for whom quinidine was not effective therapy (112±20 msec). After quinidine therapy, the mean QRS duration of patients with atherosclerotic heart disease for whom quinidine was effective therapy (123±30 msec) remained similar to that of patients with atherosclerotic heart disease for whom quinidine was not effective therapy (122±26 msec).
QRST-Integral Maps
The QRST-integral maps of the 51 normal control subjects were averaged to produce the map shown in Figure 1 . There is a smooth dipolar distribution of QRST integrals, suggesting that the ventricular recov-ery process, although not identical throughout the myocardium, changes over space very gradually. Figure 2 contains the baseline and quinidine-therapy QRST-integral maps for ventricular tachycardia patients for whom quinidine was effective therapy. Data summarizing the QRST-integral maps for all patients are compared in Table 2 . Note that the QRST-integral maps are frequently multipolar in both subgroups of ventricular tachycardia patients at baseline. The mean number of extrema per QRST-integral map was 4.7+3.4 for ventricular tachycardia patients for whom quinidine was effective therapy and 3.8±2.5 for ventricular tachycardia patients for whom quinidine was not effective therapy (p=NS). The mean number of extrema in the QRST-integral maps of ventricular tachycardia patients was significantly higher than that of the normal control group (p<0.01). The prevalence of multipolar QRSTintegral maps at baseline was 10 of 14 (71%) in ventricular tachycardia patients for whom quinidine was effective therapy and 22 of 37 (59%) for ventricular tachycardia patients for whom quinidine was not effective therapy (p=NS). The prevalence of multipolar QRST-integral maps in ventricular tachycardia patients was significantly greater than that of the normal control group (p<0.001). Thus, although baseline QRST-integral maps in ventricular tachycardia patients were different from those of control patients, they did not differ as a function of the subsequent response to quinidine therapy.
However, quinidine-induced changes in the QRSTintegral maps did differ as a function of whether or not quinidine was considered effective by programmed ven- tricular stimulation. As a group, ventricular tachycardia patients for whom quinidine was effective therapy showed no significant drug-induced changes in the number of extrema in their QRST-integral maps (4.7±3.4 versus 4.5±2.8;p=NS) or in the proportion of patients with three or more extrema (10 of 14 versus 10 of 14; p=NS). In contrast, ventricular tachycardia patients for whom quinidine was not effective therapy showed a drug-induced increase in the number of extrema in their QRST-integral maps (3.8±2.5 versus 5.4±3.4; p=0.002) and in the proportion of patients with three or more extrema (22 of 37 versus 28 of 37; p =0.13). Individually, only four of the 14 patients (29%) for whom quinidine was effective therapy showed a drug-induced increase in the number of extrema in their QRST-integral maps, whereas 23 of the 37 patients (62%) for whom quinidine was not effective therapy showed an increase in the number of extrema in their QRST-integral maps (p=0.03). Correspondingly, six of the 14 patients (43%) for whom quinidine was effective therapy showed a drug-induced decrease in the number of extrema in their QRST-integral maps, whereas only five of the 37 patients (14%) for whom quinidine was not effective therapy showed a decrease in the number of extrema in their QRST-integral maps (p=0.02). Table 3 presents group QRST-integral map extrema number data for the 40 patients with atherosclerotic heart disease. The results of this analysis mirror those of the larger group. Nevertheless, two differences (both present in a directional sense in the total population) became statistically significant in the atherosclerotic heart disease population: the increase in the proportion of patients with three or more QRST-integral extrema after quinidine therapy and the difference in mean extrema numbers after quinidine therapy between those patients for whom quinidine was effective therapy and those for whom it was not effective therapy. Individually, only two of the eight patients (25%) with atherosclerotic heart disease for whom quinidine was effective therapy showed a drug-induced increase in the number of extrema in their QRST-integral maps, whereas 22 of the 32 patients (69%) with atherosclerotic heart disease for whom quinidine was not effective therapy showed an increase in the number of extrema in the QRST-integral maps (p=0.02). Correspondingly, four of the eight patients (50%) with atherosclerotic heart disease for whom quinidine was effective therapy showed a drug-induced decrease in the number of extrema in their QRST-integral maps, whereas only four of the 32 patients (13%) with atherosclerotic heart disease for whom quinidine was not effective therapy showed a decrease in the number of extrema in the QRST-integral maps (p=0.02).
Eigenvector Analysis
The QRST-integral maps at baseline and after quinidine therapy for the ventricular tachycardia patients for whom quinidine was effective therapy are presented in Figure 3 as a series of spatial eigenvector patterns in descending order of their percentage contribution to the total map. Note that both at baseline and after quinidine therapy, the first three eigenvec- 3 . Spatial eigenvector patterns contributing to total QRST-integral body surface map at baseline (left plot of each column) and after quinidine therapy (right plot of each column) for the 14 ventricular tachycardia patients for whom quinidine was effective therapy. Percentage contribution of each eigenvector pattern to total map is indicated.
tors are dipolar, whereas eigenvectors 4 through 12 are increasingly multipolar. The nondipolar content, indicated by the contributions of eigenvectors 4 through 12, for all patients are given in Table 4 . Calculated in this way, the percentage nondipolar content in the baseline QRST-integral maps was 11.0+5.6% in ventricular tachycardia patients for whom quinidine was effective therapy and 12.9 + 11.4% for ventricular tachycardia patients for whom quinidine was not effective therapy (p=NS). The percentage nondipolar content in the baseline QRST-integral maps of ventricular tachycardia patients was greater than that of the normal control group (p<0.001). Defining the upper limit of the normal percentage nondipolar content as the normal group mean plus 2 SD (14.3%), five of the 14 ventricular tachycardia patients (36%) for whom quinidine was effective therapy and 12 of the 37 ventricular tachycardia patients (32%) for whom quinidine was not effective therapy had abnormally high percentages of nondipolar content at baseline (p=NS). As a group, the nondipolar content increased slightly after quinidine therapy in ventricular tachycardia patients for whom quinidine was effective therapy to 13.0+12.0% and in ventricular tachycardia . Spatial eigenvector patterns contributing to total QRST-integral body surface map at baseline (left plot of each column) and after quinidine therapy (right plot of each column) for the 37 ventricular tachycardia patients for whom quinidine was not effective therapy. Percentage contribution of each eigenvector pattern to total map is indicated.
patients for whom quinidine was not effective therapy to 16 .1+19.0% (p=NS). Individually, the percentage of nondipolar content was increased after therapy in six of the 14 patients (43%) for whom quinidine was effective therapy and in 20 of the 37 patients (54%) for whom quinidine was not effective therapy (p=NS). A review of the eigenvector plots ( Figure 3 ) reveals that the first plot is very similar before and after quinidine therapy. However, the magnitudes of the information contributions of eigenvectors 2 and 3 to the total QRST-integral maps after quinidine therapy are reversed in ventricular tachycardia patients for whom quinidine was effective therapy. In contrast, the contributions of eigenvectors 2 and 3 were not reversed in ventricular tachycardia patients for whom quinidine was not effective therapy ( Figure 4) . Table 5 lists the results of group eigenvector analysis for the 40 patients with atherosclerotic heart disease. The results of this analysis are similar to those of the larger group, although the difference in percentages of nondipolar content after quinidine therapy between those patients for whom quinidine was effective therapy and those for whom it was not effective therapy now was of borderline statistical significance (p=0.07). Separation of ventricular tachycardia patients for whom quinidine was or was not effective therapy by quinidine-induced changes in the percentage nondipolar content for decision thresholds of -25%0, -10%, -5%o, 0%, +5%, +10%, +20%, and +40%.
Receiver Operating Characteristic Analysis
To compare the performances of various decision thresholds in discrimination between ventricular tachycardia patients and normal subjects and between ventricular tachycardia patients for whom quinidine was or was not effective therapy, receiver operating characteristic (ROC) analyses were performed. The outcomes of these analyses, presented as ROC curves of sensitivity (true positive fraction) versus 1-specificity (false positive fraction) for each decision threshold, are shown in Figure 5 . The ROC curve of a useful test shows significant departure from the line of equivalence of sensitivity and 1-specificity. The ROC curve of a nonpredictive test is indistinguishable from the line of equivalence of sensitivity and 1-specificity. The ROC curve representing the performances of various thresholds for the number of QRST-integral map extrema for discrimination between ventricular tachycardia patients and normal subjects is shown in panel A of Figure 5 . As all subjects have two or more extrema, the usable portion of this curve is limited to its high specificity/low sensitivity extreme. The ROC curve representing the performances of various thresholds for percentage nondipolar content for discrimination between ventricular tachycardia patients and normal subjects is shown in panel B of Figure 5 . The discriminative performance of this measure is more balanced between sensitivity and specificity. The ROC curve representing performance of various thresholds for quinidine-induced changes in the number of QRST-integral map extrema for discrim-ination between patients for whom quinidine was or was not effective therapy is shown in panel C of Figure 5 . The performance of this test is also reasonably balanced between sensitivity and specificity. However, as indicated by the closer position of the ROC curve to the line of equivalence of sensitivity and 1-specificity, the discriminative power in this instance is only moderate. The ROC curve representing the performance of various thresholds for quinidine-induced changes in percentage nondipolar content for discrimination between patients for whom quinidine was or was not effective therapy is shown in Panel D of Figure 5 . This ROC curve cannot be distinguished from the line of equivalence of sensitivity and 1-specificity, indicating that this measure has no value with respect to prediction of quinidine efficacy. Relations to Ventricular Tachycardia Characteristics Analysis to this point has focused on the electrophysiological characteristic of ventricular tachycardia inducibility. Linear regression was used to examine the relations between QRST-integral map data and induced ventricular tachycardia characteristics. Specifically, associations were sought between number of extrema or percentage nondipolar content and the stage of stimulation inducing ventricular tachycardia or the cycle length of induced ventricular tachycardia. No statistically significant associations between these ventricular tachycardia characteristics and the percentage nondipolar content could be demonstrated. However, the cycle length of induced ventricular tachycardia was correlated with the number of extrema (r=0.32,p=0.02 considering only baseline studies; r=0.38, p<O.OOl combining baseline and quinidine studies). This correlation was positive, with longer ventricular tachycardia cycle lengths occurring in patients with greater numbers of extrema.
Discussion
In this study and others,13-'6 patients with ventricular tachyarrhythmias had multipolar QRST-integral maps. This finding is consistent with both theoretical23 and experimental observations24 suggesting that such a pattern primarily reflects dispersion of ventricular recovery properties and hence a greater vulnerability to reentrant arrhythmias. Unlike previous studies, the patients reported in the present study were free of antiarrhythmic drug therapy at the time of body surface mapping, and the maps were acquired in close proximity to a programmed ventricular stimulation study that documented each patient's vulnerability to ventricular tachycardia.
Baseline QRST-Integral Map Data
In the present study, the multipolarity of each QRSTintegral map was evaluated by counting the number of extrema and by calculating the percentage nondipolar content from the weighting coefficients of spatial eigenvector patterns. Although these two measures are related, the results of this study indicate that the map properties reflected in each measure have important differences. When multipolar QRST-integral maps are defined as those with three or more extrema, abnormal QRST-integral maps were observed in 63% of our ventricular tachycardia patients and 4% of our normal subjects. Previous studies using this measure have reported the proportion of ventricular tachycardia patients with three or more extrema to range from the 12% reported by Green et a125 to the 66% reported by Gardner et al. 26 The results of our larger study population favor the higher end of this range. When multipolar QRST-integral maps are defined as those with percentage nondipolar contents more than 2 SD greater than the mean of a normal population, abnormal maps were defined as those with >14.3% nondipolar content and were observed in 33% of our ventricular tachycardia patients and 4% of our normal subjects. Application of the same process to data reported by Abildskov et a12' would define abnormal QRST-integral maps as those with >26.6% nondipolar content, which were observed in approximately 58% of their ventricular tachycardia patients and 4% of their normal subjects (estimates from Figure 4 of Reference 21). De Ambroggi et al15 have applied the same process to a patient population with the idiopathic long QT interval syndrome. Their data defined abnormal QRST-integral maps as those with >7.2% nondipolar content, which were observed in 36% of their long QT interval syndrome patients and 4% of their normal control subjects.
Of course, the discrimination performances of these two measures of the multipolarity of QRST-integral maps are dependent on the thresholds used to separate normal from abnormal. To evaluate the performance of these two measures independently of decision thresholds, ROC analyses were performed. For the purpose of ble performance. However, the number of extrema was a specific indicator of vulnerability to ventricular tachyarrhythmias, whereas the calculated percentage nondipolar content was more balanced in terms of sensitivity and specificity.
The two measures of the multipolarity of QRSTintegral maps also differed in that there was no relation between percentage nondipolar content and the characteristics of induced ventricular tachycardia. On the other hand, the number of extrema correlated with the cycle length of induced ventricular tachycardia. This observation supports the presence of a relation between the cycle length of induced ventricular tachycardia and ventricular repolarization properties.
QRST-Integral Map Measurement of Quinidine Effects
The primary purposes of this study were to determine whether there are features on the baseline QRSTintegral map that might predict which patients will respond to drug therapy and whether therapy-induced changes in QRST-integral maps correlate with antiarrhythmic efficacy. To maintain drug-effect homogeneity in this evaluation, only the effects of quinidine were assessed in this analysis. Unfortunately, no feature of the baseline QRST-integral maps of ventricular tachycardia patients correlated with a subsequent antiarrhythmic response to quinidine. However, changes in QRST-integral maps associated with quinidine treatment did predict an antiarrhythmic response. We hypothesized that antiarrhythmic drug therapy considered effective by programmed ventricular stimulation would "improve" abnormal baseline map features. In fact, the proportion of patients whose abnormal baseline map features improved was greater among those for whom quinidine was effective therapy. However, on average in this group, the posttreatment maps were changed little from the baseline state, with no significant reduction in the mean number of extrema in their QRST-integral maps or the proportion of patients with three or more extrema. Nevertheless, in ventricular tachycardia patients for whom quinidine was not effective therapy, the treatment was associated with significant "worsening" of arrhythmogenic map features. These features included an increase in the mean number of extrema in their QRST-integral maps and an increase in the proportion of patients with three or more extrema. Although changes in the number of extrema in QRSTintegral maps associated with quinidine therapy predict the antiarrhythmic response to that therapy, changes in the calculated percentage nondipolar content were not predictive. This difference between the two measures of multipolarity of QRST-integral maps was also demonstrated in the receiver operating characteristic analysis. Nevertheless, the magnitudes of the contributions of eigenvectors 2 and 3 to posttreatment QRST maps are reversed in ventricular tachycardia patients for whom quinidine is effective therapy but not in ventricular tachycardia patients for whom quinidine is not effective therapy. This interesting observation requires further examination. For example, it raises the question as to whether further analysis might uncover features unique to eigenvectors 2 and 3 that will add to our understanddistinguishing ventricular tachycardia patients from normal subjects, the two measures exhibited compara-ing of the mechanisms underlying antiarrhythmic drug efficacy. The potential importance of these observations is underscored by noting that no other noninvasive examination has yet been shown to be capable of predicting the results of an antiarrhythmic drug trial assessment by programmed ventricular stimulation. This finding could contribute to the ultimate development of an effective noninvasive predictor of antiarrhythmic drug efficacy.
Potential Limitations
Throughout this study, changes in QRST integrals have been ascribed to changes in regional differences of ventricular recovery properties. There is a sound theoretical basis for relating the QRST integral to disparity of ventricular repolarization properties,27-29 and this relation is substantiated by experimental evidence. '2,21'30"31 Nevertheless, recent evidence has documented changes in QRST integrals as a consequence of changes in ventricular activation sequence.10 However, changes in QRST integrals resulting from major differences in activation sequence (left versus right ventricular pacing) were subtle.10 Furthermore, in the present study, druginduced QRST-integral differences between those patients for whom quinidine was effective therapy and those patients for whom quinidine was not effective occurred despite the absence of differences between these two groups in drug-induced changes in activation sequence to the extent that these were reflected by prolongation of QRS duration. Accordingly, the QRSTintegral findings reported here have been ascribed primarily to drug-induced changes in regional differences of ventricular repolarization properties.
In order to minimize the possibility of bias in the patient selection process, consecutive patients presenting with documented ventricular tachyarrhythmias and inducible ventricular tachycardia who underwent a trial of quinidine therapy were enrolled. As indicated above, there were significant differences between patients for whom quinidine was effective therapy and those for whom quinidine was not effective in terms of the type of underlying structural heart disease. However, this difference does not explain the findings reported here, because a subgroup analysis limited to patients with atherosclerotic heart disease was indistinguishable from the findings of the analysis of the total patient population.
Conclusions
Although the results of studies at our center3 and others3233 have indicated that programmed ventricular stimulation is a useful approach to assessment of vulnerability to ventricular tachyarrhythmias and the selection of antiarrhythmic drug therapy, the technique has obvious shortcomings. It requires the induction of potentially life-threatening arrhythmias, necessitates invasive instrumentation, and must be repeated on multiple occasions to test different therapies. Other noninvasive methods, such as documentation of ventricular premature beat frequency by ambulatory ECG monitoring and exercise testing, are less expensive and more acceptable to patients but provide less specific assessment of vulnerability to ventricular tachyarrhythmias.1-3,32,33 More promising noninvasive techniques include measurement of abnormal intraventricular conduction with a signalaveraged three-lead ECG and measurement of abnormal dispersion of refractoriness with ECG body surface mapping. The relative values of the latter two techniques in assessment of vulnerability to ventricular tachyarrhythmias have not yet been evaluated. Nevertheless, other investigators have demonstrated that the body surface mapping approach does provide information content in excess of that provided from the three leads used in signal-averaged electrocardiography. 34 The results of the present study indicate that QRSTintegral maps are uniquely altered in those patients for whom quinidine is effective antiarrhythmic therapy as defined by the results of baseline and treatment programmed ventricular stimulation studies.
